Literature DB >> 711927

Contribution to the pharmacokinetics of amitriptyline.

V E Ziegler, J T Biggs, A B Ardekani, S H Rosen.   

Abstract

The clinical pharmacokinetics of amitriptyline were studied in four volunteers after the oral administration of 75 mg. Peak amitriptyline plasma concentrations ranged from 10.8 to 43.7 ng/ml. The disappearance was biphasic and followed first-order kinetics. The mean elimination half-life was 36.1 hours. The mean estimated first-pass metabolism of amitriptyline was 60 per cent. Significant quantities of the metabolite, nortriptyline, were produced although peak concentrations ranged from only 5.9 to 12.3 ng/ml. The relationship between these findings to clinical practice and earlier reports is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 711927     DOI: 10.1002/j.1552-4604.1978.tb01572.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  11 in total

1.  Antidepressant and Antipsychotic Drugs.

Authors:  Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2010-12-01

2.  Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons.

Authors:  Jared Minkel; Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 3.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

4.  Influence of age on mianserin pharmacokinetics.

Authors:  A C Altamura; T Melorio; G Invernizzi; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 5.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

Review 6.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

7.  Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.

Authors:  A C Altamura; T Melorio; G Invernizzi; F Colacurcio; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction.

Authors:  P Dorian; E M Sellers; K L Reed; J J Warsh; C Hamilton; H L Kaplan; T Fan
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Amitriptyline pharmacokinetics. A crossover study with single doses of amitriptyline and nortriptyline.

Authors:  J E Burch; R P Hullin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Urinary excretion of conjugates of dothiepin and northiaden (mono-N-demethyl-dothiepin) after an oral dose of dothiepin to humans.

Authors:  K Kawahara; T Awaji; K Uda; Y Sakai; Y Hashimoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.